Clinical Trials on Thirst in France

Total 43 results

Assistance Publique - Hôpitaux de Paris

Recruiting

Thirst in the Intensive Care Unit, Recognition, Sensitivity and Type (THIRST)

Thirst in Intensive Care Unit (ICU) Practice

France
University Hospital, Strasbourg, France

Unknown

Abortions at Strasbourg University Hospitals

First-trimester Pregnancy

France
University of Paris 5 - Rene Descartes

Unknown

Empathy and Emotional Intelligence Promoted by the Selection Process in 1st Year of Health Studies at the Paris University Medical School (PREMIS)

Health Studies First-year Course Selection

France
Central Hospital, Nancy, France

Terminated

First-time Fathers' Experiences of Childbirth in Lorraine (PRIMIPERE)

First Birth | Fathers

France
Nantes University Hospital

Terminated

Evaluation of an Early Screening Test of Chronic Rejection and of Operational Tolerance by MicroArray in Renal Graft (Protocol DPRC Array)

First Cadaveric Renal Graft

France
Centre Hospitalier Universitaire de Nīmes

Completed

Postoperative Analgesia Following Wisdom Teeth Removal: Ropivacaine Versus Placebo (RopiMol)

Third Molar Extraction

France
Dr.Laurent Mineur
Merck Serono International SA; BESPIM, CHU Nîmes (data analysis)

Unknown

PREMIUM, Observational Study

First Line WT KRAS mCRC

France
Assistance Publique - Hôpitaux de Paris
Institut Pasteur; Pathogen Discovery Laboratory

Recruiting

Metatranscriptomic Next Generation Sequencing in First Trimester Trophoblast With Increased Fetal Nuchal Translucency (METAHCN) (METAHCN)

Increased Nuchal Translucency in the First Trimester of Pregnancy

France
Symatese

Unknown

Evaluation of NEVELIA® in Terms of Safety and Efficacy for Third-degree Burns Treatment or Reconstructive Surgery (NEVAL)

Third-degree Burns | Reconstructive Surgery

France
Assistance Publique - Hôpitaux de Paris

Completed

Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of First Rank Symptoms (FRS) on Schizophrenia (Schirang)

Schizophrenia Patients With First Rank Symptoms

France
University Hospital, Grenoble
Société Française d'Anesthésie et de Réanimation

Completed

eFast Diagnosis Performance in Guiding First Aid Resuscitation (eFAST Decision)

eFast Diagnosis Performance in Guiding First Aid Resuscitation and Hemostasis

France
Centre Hospitalier Universitaire de Nīmes

Completed

Evaluation of Case Management for First Episode Psychosis Using the PEPsy-CM Checklist (CHECKLISTPEP)

First Episode Psychosis

France
Assistance Publique Hopitaux De Marseille

Completed

Feasibility and Acceptability of an Educational Intervention to Improve the Management of Depression in Primary Care.

Patients With Moderate Depression, | First or Second Episode

France
University Hospital, Clermont-Ferrand

Completed

Impact of Systemic Corticosteroid Therapy on Lens Transparency and Quantification of Lens Autofluorescence.

Patients With Systemic Inflammatory Diseases Receiving for the First Time a Protracted General Corticostroid Therapy

France
University Hospital, Strasbourg, France

Unknown

TREatment of Uretral STRICTure With Self-catheterization : Tolerance Evaluation (TRESTRICTT)

First or Second Uretral Stenosis | Diagnosed With Uretral Fibroscopy

France
ARCAGY/ GINECO GROUP

Terminated

1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer

First Line Metastatic Breast Cancer

France
Hospices Civils de Lyon

Unknown

Predictive Value of Aortic Stiffness on Recurrence of Atrial Fibrillation After Disconnection of Pulmonary Veins (VARIABLE). (VARIABLE)

First Ablation of Atrial Fibrillation

France
NHS Lothian

Completed

Delivery of Audiovisual Information on Early Medical Abortion (EMAVID)

Abortion in First Trimester | Abortion Early

Sweden, United Kingdom, France
University Hospital, Brest

Not yet recruiting

Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode (PEPAMARKER)

First-episode Psychosis

France
Assistance Publique - Hôpitaux de Paris

Completed

Efficiency of Levamisole for Maintaining Remission After the First Flare of Steroid Sensitive Nephrotic Syndrome in Children (NEPHROVIR3)

First Manifestation of Steroid Sensitive Nephrotic Syndrome

France
Centre Jean Perrin

Completed

Individualization of Dosage of Irinotecan in the FOLFIRI According to the Genetic Polymorphism of UGT1A1 in the First Line Treatment of Metastatic Colorectal Cancer (IriGen)

First Line Metastatic Colorectal Cancer

France
Centre Hospitalier Universitaire, Amiens

Completed

Comparison of the Bilateral TAP Block Versus Curare in Muscle Relaxation of the Abdominal Wall During Laparoscopic Digestive Surgery: Prospective Randomized Study

The Main of This Study is to Compare the Nerve Block of the Muscles of the Abdominal Wall Between the Bilateral TAP Block and Curare

France
Centre Georges Francois Leclerc

Recruiting

Influence of Food Preferences on the Occurrence of Undernutrition in Treated Patients for Bronchopulmonary Carcinoma Non-small Cell Stage IV (ONCOGOU)

Non-small Cell Bronchopulmonary Carcinoma at Stage IV and Benefiting From First-line Treatment According to Current French Recommendations

France
Hospices Civils de Lyon

Unknown

Formation of Health Professionals Through in Situ Simulation to Improve Performances During the Initial Step of Thrombectomy for Ischemic Strokes (OPTISS)

Time | Benefit of in Situ Simulation for This Kind of Training | Installation of the Patient Until the Percutaneous

France
Assistance Publique - Hôpitaux de Paris

Completed

Future of Spermatogenesis in Men With Sickle Cell Disease Medically Treated (HYDREP)

Drepanocytic Men Treated by Hydroxyurea for the First Time

France
University Hospital, Angers

Unknown

Use of Arterio-venous Fistula as First Choice for Intravenous Drug Administration in Kidney Transplant Recipients (PerFAV)

Evaluate the Risks of Using Arteriovenous Fistula as First Choise for Drug Administration

France
Centre Hospitalier Universitaire Dijon

Unknown

AGARIC Case Control Study (AGARIC)

First Recently-diagnosed Colorectal Cancer

France
Assistance Publique - Hôpitaux de Paris
COVIREIVAC

Active, not recruiting

Compare Immunological Efficacy of a Vaccine Regimen Combining Two Covid19 mRNA Vaccines (Pfizer-BioNTech and Moderna) With That of a Homologous Vaccination of Each Covid19 mRNA Vaccine (ARNCOMBI)

Adult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second Dose

France
Institut Curie

Recruiting

LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG (LIBERTYLUNG)

NSCLC Patient in a Metastatic Stage Eligible for First-line Treatment With Immune Checkpoint Inhibitor

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Assessment of the Applicability and Acceptability of an Algorithm to Guide the Prescription of 1st and 2nd Generation Cephalosporins as Part of Intraoperative Antibiotic Prophylaxis in Patients With a Declared Allergy to Penicillin (PROPHYLAL)

Adult Patients Who Declare an Allergy to Penicillin During Anaesthetic Consultation Without Any Allergy Work up That Could Confirm This Declaration | Good Comprehension of French Language

France
Institut Claudius Regaud

Completed

Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival (METAL3)

Metastatic Breast Cancer Starting a Third Line Chemotherapy

France
Hospices Civils de Lyon

Completed

Causes of Death in Follicular Lymphoma: a Single Center Retrospective Analysis

This Study Describes the Different Causes of Death in 237 FL Patients

France
Jules Bordet Institute
Hoffmann-La Roche

Recruiting

A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients (COPERNIC)

Metastatic Colorectal Cancer | Unresectable Locally Advanced Colorectal Cancer | Candidate for Third-line or Subsequent Lines of Therapy

Belgium, France
University Hospital, Brest

Active, not recruiting

Hydroxychloroquine for Prevention of Recurrent Miscarriage. (BBQ)

Recurrent Miscarriage | First Trimester Abortion

France
Assistance Publique - Hôpitaux de Paris

Completed

Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome) (CHUSPAN2)

MPA | PAN or EGPA With FFS=0 | At Diagnosis or Within the First 15 Days Following Initiation of Corticosteroids

France
Nantes University Hospital

Active, not recruiting

A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse." (I2D IFM2021_03)

Multiple Myeloma at First Relapse

France
Institut Curie
Celgene Corporation; Intergroupe Francophone du Myelome

Completed

A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial (PCD)

Multiple Myeloma | First Relapse

France
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

Avelumab in First-line NSCLC (JAVELIN Lung 100)

First Line Non-Small Cell Lung Cancer

Spain, United States, Hungary, Israel, China, Korea, Republic of, Taiwan, Czechia, Russian Federation, Australia, Brazil, Lebanon, Serbia, Thailand, Canada, Slovakia, Ukraine, Bulgaria, Italy, Netherlands, New Zealand, Poland, Belgium, Turk... and more
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)

Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | Gastric Cancer Third Line

Spain, Italy, Australia, Korea, Republic of, Belgium, France, Poland, United States, Czechia, Germany
Eisai Inc.

Completed

A Study to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Participants With Low CA125 Platinum-sensitive Ovarian Cancer

Platinum-Sensitive Ovarian Cancer in First Relapse

United States, Italy, United Kingdom, Germany, Spain, Belgium, Japan
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors

Glioblastoma | Astrocytoma | Anaplastic Astrocytoma | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | Diffuse Astrocytoma | Anaplastic Oligodendroglioma | Pilocytic Astrocytoma | Gangliocytoma | Central Neurocytoma | Oligodendroglioma, Childhood and other conditions

United States, Italy, Japan, Germany, Spain, France, Canada, Australia, Brazil, Israel, Russian Federation, Argentina, United Kingdom, Finland, Belgium, Denmark, Czechia, Sweden, Switzerland, Netherlands
AstraZeneca
Merck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.

Active, not recruiting

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. (SOLO-1)

Advanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum Chemotherapy

Korea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain
Novartis Pharmaceuticals

Recruiting

Pediatric Long-Term Follow-up and Rollover Study

Glioblastoma | Astrocytoma | Anaplastic Astrocytoma | Neurofibromatosis Type 1 | Anaplastic Ganglioglioma | Anaplastic Pleomorphic Xanthoastrocytoma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | Diffuse Astrocytoma | Anaplastic Oligodendroglioma | Pilocytic Astrocytoma | Gangliocytoma | Central Neurocytoma | Oligodendroglioma... and other conditions

United States, Belgium, Spain, Denmark, Germany, Czechia, Italy, Australia, Russian Federation, France, Brazil, Netherlands, Japan, Canada, Finland, Sweden, United Kingdom, Argentina, Israel

Clinical Trials on Thirst in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations